Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Himadri Shekhar Roy, Gurudutt Dubey, Vishnu Kumar Sharma, Prasad V. Bharatam & Deepa Ghosh. (2022) Molecular docking and molecular dynamics to identify collagenase inhibitors as lead compounds to address osteoarthritis. Journal of Biomolecular Structure and Dynamics 40:5, pages 2339-2351.
Read now
Read now
Edward A Lin & Chuan-ju Liu. (2009) The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases. Open Access Rheumatology: Research and Reviews 1, pages 121-131.
Read now
Read now
Helmtrud I Roach. (2008) Potential directions for drug development for osteoarthritis. Expert Opinion on Drug Discovery 3:5, pages 475-486.
Read now
Read now
E. R. Garvican, A. Vaughan-Thomas, C. Redmond & P. D. Clegg. (2008) MT3-MMP (MMP-16) is Downregulated by In Vitro Cytokine Stimulation of Cartilage, but Unaltered in Naturally Occurring Equine Osteoarthritis and Osteochondrosis. Connective Tissue Research 49:2, pages 62-67.
Read now
Read now
. (2004) Cyclic sulfone hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α-converting enzymes. Expert Opinion on Therapeutic Patents 14:1, pages 121-124.
Read now
Read now
Articles from other publishers (53)
Haoyu Yu, Rongyao Gao, Yuxin Liu, Limin Fu, Jing Zhou & Luoyuan Li. (2023) Stimulus‐Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy. Advanced Science.
Crossref
Crossref
Qi Jiang & Shufang Zhang. (2023) Stimulus‐Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy. Small 19:23.
Crossref
Crossref
Taeheon Lee, Chae-Bin Na, Dasom Kim, Hae Jung Han, Jongbok Yun, Sun Kyu Park & Eunhae Cho. (2022)
Osteoarthritis improvement effect of
Chrysanthemum zawadskii
var.
latilobum
extract in relation to genotype
. International Journal for Vitamin and Nutrition Research.
Crossref
Crossref
Guangshuai Zhang, Lixue Ma, Lijun Bai, Mo Li, Tiange Guo, Baocheng Tian, Zhonggui He & Qiang Fu. (2021) Inflammatory microenvironment-targeted nanotherapies. Journal of Controlled Release 334, pages 114-126.
Crossref
Crossref
Harpal K. Gahunia & Kenneth P. H. Pritzker. 2020. Articular Cartilage of the Knee. Articular Cartilage of the Knee
123
171
.
Yaokun Li, José A. Carrillo, Yi Ding, Yanghua He, Chunping Zhao, Jianan Liu, Linsen Zan & Jiuzhou Song. (2019) DNA methylation, microRNA expression profiles and their relationships with transcriptome in grass-fed and grain-fed Angus cattle rumen tissue. PLOS ONE 14:10, pages e0214559.
Crossref
Crossref
Takashi Ohtsuki, Akira Shinaoka, Kanae Kumagishi-Shinaoka, Keiichi Asano, Omer Faruk Hatipoglu, Junko Inagaki, Ken Takahashi, Toshitaka Oohashi, Keiichiro Nishida, Keiji Naruse & Satoshi Hirohata. (2019) Mechanical strain attenuates cytokine-induced ADAMTS9 expression via transient receptor potential vanilloid type 1. Experimental Cell Research 383:2, pages 111556.
Crossref
Crossref
P. Yeung, W. Zhang, X.N. Wang, C.H. Yan & B.P. Chan. (2018) A human osteoarthritis osteochondral organ culture model for cartilage tissue engineering. Biomaterials 162, pages 1-21.
Crossref
Crossref
Thomas Fischer & Rainer Riedl. (2017) Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor. Molecules 22:9, pages 1548.
Crossref
Crossref
Yan Ma, Xuewu Sun, Kangmao Huang, Shuying Shen, Xianfeng Lin, Ziang Xie, Jiying Wang, Shunwu Fan, Jianjun Ma & Xing Zhao. (2017) Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases. Oncotarget 8:38, pages 62900-62913.
Crossref
Crossref
Thomas Fischer & Rainer Riedl. (2017) Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor. ChemistryOpen 6:2, pages 192-195.
Crossref
Crossref
John S. Mort, Yeqing Geng, William D. Fisher & Peter J. Roughley. (2016) Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Peter J Roughley & John S Mort. (2014) The role of aggrecan in normal and osteoarthritic cartilage. Journal of Experimental Orthopaedics 1:1.
Crossref
Crossref
Antonella Di PizioAntonio LaghezzaPaolo TortorellaMariangela Agamennone. (2013) Probing the S1′ Site for the Identification of Non‐Zinc‐Binding MMP‐2 Inhibitors. ChemMedChem 8:9, pages 1475-1482.
Crossref
Crossref
Satoko MatsukawaMiki TanimuraTomoko Toyosaki-MaedaAkihiro NodaMika KobayashiAkira YamauchiJunji OnodaToshinaga TsujiTatsuya TakahashiYoshiyuki MatsuoNaoshi Fukui. (2013) CIINE Reflects Collagenase-Specific CII Breakdown in Cartilage Explant and Whole Body of Canine. Biomarker Insights 8, pages BMI.S11627.
Crossref
Crossref
Antonella Di Pizio, Mariangela Agamennone & Massimiliano Aschi. (2012) An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors. PLoS ONE 7:11, pages e47774.
Crossref
Crossref
Jonathan D. Tugwood, Janet Kelsall, Lucy C. Coverley, F. Russell Westwood, Kemal Haque & Russell D. J. Huby. (2012) Fibrodysplasia Induced in Dog Skin by a Matrix Metalloproteinase (MMP) Inhibitor—A Mechanistic Analysis. Toxicological Sciences 127:1, pages 236-245.
Crossref
Crossref
Rui Sun, Zheng-yu Li, Han-jiang He, Jie Wei, Juan Wang, Qi-xian Zhang, Jia Zhao, Xi-mei Zhan & Zhong-dao Wu. (2011) Molecular cloning and characterization of a matrix metalloproteinase, from Caenorhabditis elegans: employed to identify homologous protein from Angiostrongylus cantonensis. Parasitology Research 110:5, pages 2001-2012.
Crossref
Crossref
Hanwei Li, Noel Davison, Lorenzo Moroni, Felicia Feng, Joshua Crist, Erin Salter, Clifton O. Bingham & Jennifer Elisseeff. (2012)
Evaluating Osteoarthritic Chondrocytes through a Novel 3-Dimensional
In Vitro
System for Cartilage Tissue Engineering and Regeneration
. CARTILAGE 3:2, pages 128-140.
Crossref
Crossref
Hanwei Li, Felicia Feng, Clifton O. BinghamIIIIII & Jennifer H. Elisseeff. (2012) Matrix metalloproteinases and inhibitors in cartilage tissue engineering. Journal of Tissue Engineering and Regenerative Medicine 6:2, pages 144-154.
Crossref
Crossref
Christian Gege, Bagna Bao, Harald Bluhm, Jürgen Boer, Brian M. GallagherJr.Jr., Brian Korniski, Timothy S. Powers, Christoph Steeneck, Arthur G. Taveras & Vijaykumar M. Baragi. (2012) Discovery and Evaluation of a Non-Zn Chelating, Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitor for Potential Intra-articular Treatment of Osteoarthritis. Journal of Medicinal Chemistry 55:2, pages 709-716.
Crossref
Crossref
Priyanka Verma & Krishna Dalal. (2011) ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis. Journal of Cellular Biochemistry 112:12, pages 3507-3514.
Crossref
Crossref
Paola Vicini, Lucia Crascì, Matteo Incerti, Simone Ronsisvalle, Venera Cardile & Anna Maria Panico. (2011) Benzisothiazolyliminothiazolidin-4-ones with Chondroprotective Properties: Searching for Potent and Selective Inhibitors of MMP-13. ChemMedChem 6:7, pages 1199-1202.
Crossref
Crossref
Guo-Xin Ni, Li-Qiong Zhan, Mei-Qin Gao, Lei Lei, Yue-Zhu Zhou & Yan-Xia Pan. (2011) Matrix metalloproteinase-3 inhibitor retards treadmill running-induced cartilage degradation in rats. Arthritis Research & Therapy 13:6, pages R192.
Crossref
Crossref
Marc Fajardo, Chuan-Ju Liu, Kirill Ilalov & Kenneth A Egol. (2010) Matrix Metalloproteinases That Associate With and Cleave Bone Morphogenetic Protein-2 In Vitro Are Elevated in Hypertrophic Fracture Nonunion Tissue. Journal of Orthopaedic Trauma 24:9, pages 557-563.
Crossref
Crossref
Donghong Amy Gao, Zhaoming Xiong, Alexander Heim-Riether, Laura Amodeo, E. Michael August, Xianhua Cao, Leonard Ciccarelli, Brandon K. Collins, Kyle Harrington, Kathleen Haverty, Melissa Hill-Drzewi, Xiang Li, Shuang Liang, Steluta Mariana Margarit, Neil Moss, Nelamangala Nagaraja, John Proudfoot, Rene Roman, Sabine Schlyer, Lana Smith Keenan, Steven Taylor, Bernd Wellenzohn, Dieter Wiedenmayer, Jun Li & Neil A. Farrow. (2010) SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5039-5043.
Crossref
Crossref
Dorothea Piecha, Jürgen Weik, Heike Kheil, Gabriele Becher, Andreas Timmermann, Andreas Jaworski, Maren Burger & Michael W. Hofmann. (2009) Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants. Inflammation Research 59:5, pages 379-389.
Crossref
Crossref
H. Li & J.H. Elisseeff. 2010. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues
301
329
.
Edward A. Lin & Chuan-Ju Liu. (2010) The role of ADAMTSs in arthritis. Protein & Cell 1:1, pages 33-47.
Crossref
Crossref
Tim E. Cawston & David A. Young. (2009) Proteinases involved in matrix turnover during cartilage and bone breakdown. Cell and Tissue Research 339:1, pages 221-235.
Crossref
Crossref
Russell Westwood, Robert C. Scott, Rebecca L. Somers, Michelle Coulson & Rose A. Maciewicz. (2009) Characterization of Fibrodysplasia in the Dog Following Inhibition of Metalloproteinases. Toxicologic Pathology 37:7, pages 860-872.
Crossref
Crossref
Alison K Surridge, Ursula R Rodgers, Tracey E Swingler, Rose K Davidson, Lara Kevorkian, Rosemary Norton, Jasmine G Waters, Mary B Goldring, Andrew E Parker & Ian M Clark. (2009) Characterization and regulation of ADAMTS-16. Matrix Biology 28:7, pages 416-424.
Crossref
Crossref
Alexander Heim-Riether, Steven J. Taylor, Shuang Liang, Donghong Amy Gao, Zhaoming Xiong, E. Michael August, Brandon K. Collins, Bennett T. FarmerIIII, Kathleen Haverty, Melissa Hill-Drzewi, Hans-Dieter Junker, S. Mariana Margarit, Neil Moss, Thomas Neumann, John R. Proudfoot, Lana Smith Keenan, Renate Sekul, Qiang Zhang, Jun Li & Neil A. Farrow. (2009) Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters 19:18, pages 5321-5324.
Crossref
Crossref
Z. Zainal, A.J. Longman, S. Hurst, K. Duggan, B. Caterson, C.E. Hughes & J.L. Harwood. (2009) Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis and Cartilage 17:7, pages 896-905.
Crossref
Crossref
Vijaykumar M. Baragi, Gabriel Becher, Alison M. Bendele, Ralf Biesinger, Harald Bluhm, Jürgen Boer, Hongbo Deng, Rory Dodd, Michael Essers, Tim Feuerstein, Brian M. GallagherJr.Jr., Christian Gege, Matthias Hochgürtel, Michael Hofmann, Andreas Jaworski, Lixia Jin, Andrew Kiely, Brian Korniski, Heiko Kroth, Darrell Nix, Bert Nolte, Dorothea Piecha, Timothy S. Powers, Frank Richter, Matthias Schneider, Christoph Steeneck, Irving Sucholeiki, Arthur Taveras, Andreas Timmermann, Joshua Van Veldhuizen, Juergen Weik, Xinyuan Wu & Bing Xia. (2009) A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis & Rheumatism 60:7, pages 2008-2018.
Crossref
Crossref
Changwei Ao, Anping Li, Abdelnaser A. Elzaawe & Shinkichi Tawata. (2008) MMP-13 Inhibitory Activity of Thirteen Selected Plant Species from Okinawa. International Journal of Pharmacology 4:3, pages 202-207.
Crossref
Crossref
Jie Jack Li, Joe Nahra, Adam R. Johnson, Amy Bunker, Patrick O’Brien, Wen-Song Yue, Daniel F. Ortwine, Chiu-Fai Man, Vijay Baragi, Kenneth Kilgore, Richard D. Dyer & Hyo-Kyung Han. (2008)
Quinazolinones and Pyrido[3,4-
d
]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis
. Journal of Medicinal Chemistry 51:4, pages 835-841.
Crossref
Crossref
Adam R. Johnson, Alexander G. Pavlovsky, Daniel F. Ortwine, Faith Prior, Chiu-Fai Man, Dirk A. Bornemeier, Craig A. Banotai, W. Thomas Mueller, Patrick McConnell, Chunhong Yan, Vijay Baragi, Charles Lesch, W. Howard Roark, Michael Wilson, Kaushik Datta, Roberto Guzman, Hyo-Kyung Han & Richard D. Dyer. (2007) Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects. Journal of Biological Chemistry 282:38, pages 27781-27791.
Crossref
Crossref
Phillip Johnston, Adrian J. Chojnowski, Rose K. Davidson, Graham P. Riley, Simon T. Donell & Ian M. Clark. (2007) A Complete Expression Profile of Matrix-Degrading Metalloproteinases in Dupuytren’s Disease. The Journal of Hand Surgery 32:3, pages 343-351.
Crossref
Crossref
Tim E. Cawston & Amy J. Wilson. (2006) Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Practice & Research Clinical Rheumatology 20:5, pages 983-1002.
Crossref
Crossref
H. E. Barksby, J. M. Milner, A. M. Patterson, N. J. Peake, W. Hui, T. Robson, R. Lakey, J. Middleton, T. E. Cawston, C. D. Richards & A. D. Rowan. (2006) Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: Implications for cartilage degradation in arthritis. Arthritis & Rheumatism 54:10, pages 3244-3253.
Crossref
Crossref
Ainsley C Nicholson, Shehre-Banoo Malik, John M LogsdonJrJr & Erwin G Van Meir. (2005) Functional evolution of ADAMTS genes: Evidence from analyses of phylogeny and gene organization. BMC Evolutionary Biology 5:1.
Crossref
Crossref
Douglas H. Juers, Jaeseung Kim, Brian W. Matthews & Scott McN. Sieburth. (2005)
Structural Analysis of Silanediols as Transition-State-Analogue Inhibitors of the Benchmark Metalloprotease Thermolysin
,
. Biochemistry 44:50, pages 16524-16528.
Crossref
Crossref
G. P. Riley. (2005) Gene expression and matrix turnover in overused and damaged tendons. Scandinavian Journal of Medicine and Science in Sports 15:4, pages 241-251.
Crossref
Crossref
Chris A. Peach, Andrew J. Carr & John Loughlin. (2005) Recent advances in the genetic investigation of osteoarthritis. Trends in Molecular Medicine 11:4, pages 186-191.
Crossref
Crossref
Julian A. Blagg, Mark C. Noe, Lilli A. Wolf-Gouveia, Lawrence A. Reiter, Ellen R. Laird, Shang-Poa P. Chang, Dennis E. Danley, James T. Downs, Nancy C. Elliott, James D. Eskra, Richard J. Griffiths, Joel R. Hardink, Amber I. Haugeto, Christopher S. Jones, Jennifer L. Liras, Lori L. Lopresti-Morrow, Peter G. Mitchell, Jayvardhan Pandit, Ralph P. Robinson, Chakrapani Subramanyam, Marcie L. Vaughn-Bowser & Sue A. Yocum. (2005) Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14. Bioorganic & Medicinal Chemistry Letters 15:7, pages 1807-1810.
Crossref
Crossref
Soong-Hoon Kim, Andrew T. Pudzianowski, Kenneth J. Leavitt, Joseph Barbosa, Patricia A. McDonnell, William J. Metzler, Bruce M. Rankin, Richard Liu, Wayne Vaccaro & William Pitts. (2005) Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13). Bioorganic & Medicinal Chemistry Letters 15:4, pages 1101-1106.
Crossref
Crossref
Aranapakam M. Venkatesan, Jamie M. Davis, George T. Grosu, Jannie Baker, Arie Zask, Jeremy I. Levin, John Ellingboe, Jerauld S. Skotnicki, John F. DiJoseph, Amy Sung, Guixian Jin, Weixin Xu, Diane Joseph McCarthy & Dauphine Barone. (2004) Synthesis and Structure−Activity Relationships of 4-alkynyloxy Phenyl Sulfanyl, Sulfinyl, and Sulfonyl Alkyl Hydroxamates as Tumor Necrosis Factor-α Converting Enzyme and Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry 47:25, pages 6255-6269.
Crossref
Crossref
Lawrence A. Reiter, Ralph P. Robinson, Kim F. McClure, Christopher S. Jones, Matthew R. Reese, Peter G. Mitchell, Ivan G. Otterness, Marcia L. Bliven, Jennifer Liras, Santo R. Cortina, Kathleen M. Donahue, James D. Eskra, Richard J. Griffiths, Mary E. Lame, Arturo Lopez-Anaya, Gary J. Martinelli, Shunda M. McGahee, Sue A. Yocum, Lori L. Lopresti-Morrow, Lisa M. Tobiassen & Marcie L. Vaughn-Bowser. (2004) Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1. Bioorganic & Medicinal Chemistry Letters 14:13, pages 3389-3395.
Crossref
Crossref
Robert J. Cherney, Ruowei Mo, Dayton T. Meyer, Karl D. Hardman, Rui-Qin Liu, Maryanne B. Covington, Mingxin Qian, Zelda R. Wasserman, David D. Christ, James M. Trzaskos, Robert C. Newton & Carl P. Decicco. (2004) Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry 47:12, pages 2981-2983.
Crossref
Crossref
Tim E. Cawston & Andrew D. Rowan. 2004. Cytokines and Joint Injury. Cytokines and Joint Injury
189
220
.
Lara Kevorkian, David A. Young, Clare Darrah, Simon T. Donell, Lee Shepstone, Sarah Porter, Sarah M. V. Brockbank, Dylan R. Edwards, Andrew E. Parker & Ian M. Clark. (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis & Rheumatism 50:1, pages 131-141.
Crossref
Crossref
Jian Jeffrey Chen, Nolan Dewdney, Xiaohong Lin, Robert L Martin, Keith A.M Walker, Jane Huang, Frances Chu, Elsie Eugui, Anna Mirkovich, Yong Kim, Keshab Sarma, Humberto Arzeno & Harold E Van Wart. (2003) Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs. Bioorganic & Medicinal Chemistry Letters 13:22, pages 3951-3954.
Crossref
Crossref